aTYR PHARMA INC Other Nonoperating Income (Expense)
aTYR PHARMA INC (ATYR) reported Other Nonoperating Income (Expense) of -$1.70 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-26.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2019-03-26
- aTYR PHARMA INC other nonoperating income (expense) for the quarter ending 2018-12-31 was -$359.00K.
- aTYR PHARMA INC other nonoperating income (expense) for the quarter ending 2018-09-30 was -$437.00K.
- aTYR PHARMA INC other nonoperating income (expense) for the quarter ending 2018-06-30 was -$452.00K.
- aTYR PHARMA INC other nonoperating income (expense) for the quarter ending 2018-03-31 was -$447.00K.
- aTYR PHARMA INC other nonoperating income (expense) for fiscal 2018 was -$1.70M.
- aTYR PHARMA INC other nonoperating income (expense) for fiscal 2017 was -$1.06M, a 1733.85% decline from fiscal 2016.
- aTYR PHARMA INC other nonoperating income (expense) for fiscal 2016 was $65.00K.
- aTYR PHARMA INC other nonoperating income (expense) for fiscal 2015 was -$386.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | -$359.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$796.00K derived: sum of 2 quarters · filed 2019-03-26 | -$1.25M derived: sum of 3 quarters · filed 2019-03-26 | -$1.70M 10-K · filed 2019-03-26 | |
| 2018-09-30 | -$437.00K 10-Q · filed 2018-11-14 | -$889.00K derived: sum of 2 quarters · filed 2018-11-14 | -$1.34M 10-Q · filed 2018-11-14 | -$1.61M derived: sum of 4 quarters · filed 2019-03-26 | |
| 2018-06-30 | -$452.00K 10-Q · filed 2018-08-14 | -$899.00K 10-Q · filed 2018-08-14 | -$1.17M derived: sum of 3 quarters · filed 2019-03-26 | -$1.54M derived: sum of 4 quarters · filed 2019-03-26 | |
| 2018-03-31 | -$447.00K 10-Q · filed 2018-05-15 | -$721.00K derived: sum of 2 quarters · filed 2019-03-26 | -$1.08M derived: sum of 3 quarters · filed 2019-03-26 | -$1.31M derived: sum of 4 quarters · filed 2019-03-26 | |
| 2017-12-31 | -$274.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$637.00K derived: sum of 2 quarters · filed 2019-03-26 | -$868.00K derived: sum of 3 quarters · filed 2019-03-26 | -$1.06M 10-K · filed 2019-03-26 | |
| 2017-09-30 | -$363.00K 10-Q · filed 2018-11-14 | -$594.00K derived: sum of 2 quarters · filed 2018-11-14 | -$788.00K 10-Q · filed 2018-11-14 | -$847.00K derived: sum of 4 quarters · filed 2019-03-26 | |
| 2017-06-30 | -$231.00K 10-Q · filed 2018-08-14 | -$425.00K 10-Q · filed 2018-08-14 | -$484.00K derived: sum of 3 quarters · filed 2019-03-26 | -$438.00K derived: sum of 4 quarters · filed 2019-03-26 | |
| 2017-03-31 | -$194.00K 10-Q · filed 2018-05-15 | -$253.00K derived: sum of 2 quarters · filed 2019-03-26 | -$207.00K derived: sum of 3 quarters · filed 2019-03-26 | -$157.00K derived: sum of 4 quarters · filed 2019-03-26 | |
| 2016-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$13.00K derived: sum of 2 quarters · filed 2019-03-26 | $37.00K derived: sum of 3 quarters · filed 2019-03-26 | $65.00K 10-K · filed 2019-03-26 | $36.00K 10-K · filed 2017-03-16 |
| 2016-09-30 | $46.00K 10-Q · filed 2017-11-14 | $96.00K derived: sum of 2 quarters · filed 2017-11-14 | $124.00K 10-Q · filed 2017-11-14 | $85.00K derived: sum of 4 quarters · filed 2018-03-20 | |
| 2016-06-30 | $50.00K 10-Q · filed 2017-08-14 | $78.00K 10-Q · filed 2017-08-14 | $39.00K derived: sum of 3 quarters · filed 2018-03-20 | $23.00K derived: sum of 4 quarters · filed 2018-03-20 | |
| 2016-03-31 | $28.00K 10-Q · filed 2017-05-11 | -$11.00K derived: sum of 2 quarters · filed 2018-03-20 | -$27.00K derived: sum of 3 quarters · filed 2018-03-20 | -$209.00K derived: sum of 4 quarters · filed 2018-03-20 | |
| 2015-12-31 | -$39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | -$55.00K derived: sum of 2 quarters · filed 2018-03-20 | -$237.00K derived: sum of 3 quarters · filed 2018-03-20 | -$386.00K 10-K · filed 2018-03-20 | -$357.00K 10-K · filed 2016-03-30 |
| 2015-09-30 | -$16.00K 10-Q · filed 2016-11-14 | -$198.00K derived: sum of 2 quarters · filed 2016-11-14 | -$347.00K 10-Q · filed 2016-11-14 | -$355.00K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-06-30 | -$182.00K 10-Q · filed 2016-08-10 | -$331.00K 10-Q · filed 2016-08-10 | -$339.00K derived: sum of 3 quarters · filed 2017-03-16 | -$739.00K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-03-31 | -$149.00K 10-Q · filed 2016-05-11 | -$157.00K derived: sum of 2 quarters · filed 2017-03-16 | -$557.00K derived: sum of 3 quarters · filed 2017-03-16 | -$782.00K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2014-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$408.00K derived: sum of 2 quarters · filed 2017-03-16 | -$633.00K derived: sum of 3 quarters · filed 2017-03-16 | -$796.00K 10-K · filed 2017-03-16 | |
| 2014-09-30 | -$400.00K 10-Q · filed 2015-11-10 | -$625.00K derived: sum of 2 quarters · filed 2015-11-10 | -$788.00K 10-Q · filed 2015-11-10 | ||
| 2014-06-30 | -$225.00K 10-Q · filed 2015-08-12 | -$388.00K 10-Q · filed 2015-08-12 | |||
| 2014-03-31 | -$163.00K 10-Q · filed 2015-06-18 | ||||
| 2013-12-31 | -$472.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |